Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors.
about
Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectivesHigh-sensitivity troponin T: a biomarker for diuretic response in decompensated heart failure patients.Influence of spironolactone on matrix metalloproteinase-2 in acute decompensated heart failure.Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.Effect of low-dose diuretics on the level of serum cystatin C and prognosis in patients with asymptomatic chronic heart failure.Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHFEnlarging Red Blood Cell Distribution Width During Hospitalization Identifies a Very High-Risk Subset of Acutely Decompensated Heart Failure Patients and Adds Valuable Prognostic Information on Top of HemoconcentrationTailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF).Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect.A combined clinical and biomarker approach to predict diuretic response in acute heart failure.Anemia is associated with an increased central venous pressure and mortality in a broad spectrum of cardiovascular patients.Lack of Diuretic Efficiency (but Not Low Diuresis) Early in An Acutely Decompensated Heart Failure Episode Is Associated with Increased 180-Day Mortality.Red cell distribution width predicts death and appropriate therapy in patients with implantable cardioverter defibrillator: A simple measurement with prognostic value in a variety of diseases, may help in better selection of patients who will benefiClinical and echocardiographic correlates of serum copper and zinc in acute and chronic heart failure
P2860
Q26741152-C73A0834-8289-49AB-9C64-5894375AAD6EQ30854596-2C45D7DD-51ED-420D-99EB-7B7661D11EC3Q35557972-04FCD5FC-9AF6-4820-B392-C80CB55C9A85Q36214915-38C98910-4980-4BFA-BCC1-375D3863D61EQ36334710-C421A9D2-68FF-4CE8-B678-7FD043567A26Q37184401-8B8330DA-5957-4D50-9DBF-3BC4CA821201Q37206834-575C09FF-D18A-4F03-B812-4F1795F74E12Q38731482-F00BF5AF-6ED5-4A32-AD9D-9491DDE732FAQ40231911-793C8F69-772E-400F-B283-154B7D848E1CQ41090275-33A0FC36-CE1D-4F9B-812A-0DC935B0CE25Q41476569-8CC32449-F09A-4297-A876-F725B23B3420Q44842334-92FD5C33-552C-4FC1-BC46-CF50AA4E9CDDQ47346771-555D639C-310E-4EC4-96BC-89CA464C42C0Q47412855-75BDE453-E4CC-4CDB-8B69-A35342AA7B09Q59218510-6E0B7D74-6906-4BFD-9584-DF1E4473A91D
P2860
Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tailoring diuretic therapy in ...... diuretic response predictors.
@en
Tailoring diuretic therapy in ...... diuretic response predictors.
@nl
type
label
Tailoring diuretic therapy in ...... diuretic response predictors.
@en
Tailoring diuretic therapy in ...... diuretic response predictors.
@nl
prefLabel
Tailoring diuretic therapy in ...... diuretic response predictors.
@en
Tailoring diuretic therapy in ...... diuretic response predictors.
@nl
P2860
P50
P1476
Tailoring diuretic therapy in ...... y diuretic response predictors
@en
P2093
Irene Marques
P2860
P2888
P304
P356
10.1007/S00392-013-0588-8
P577
2013-07-10T00:00:00Z